SCHEMBL14022352

SCHEMBL14022352

CC(O)c1ccn(C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21391742 0.76 INMT (0.33) —
SCHEMBL4364151 0.76 — —
Hydrochloric Acid SCHEMBL26985849 0.74 ADRB2 (0.38) —
SCHEMBL20813265 0.73 — —
SCHEMBL12534004 0.73 ALDH1A1 (0.37) —
SCHEMBL16280935 0.71 INMT (0.30) —
SCHEMBL24814002 0.70 — —
SCHEMBL20706591 0.70 RIPK1 (0.33) —
SCHEMBL18951783 0.70 UGT2B7 (0.31) —
SCHEMBL7810428 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809554-B2 Process for the preparation of sulfamide derivatives JANSSEN PHARMACEUTICA NV (BE) 2014-08-19 — — US disclosed
WO-2008143729-A2 MACROLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME RIB-X PHARMACEUTICALS, INC. (US) 2008-11-27 — — WO disclosed
WO-2008143730-A2 MACROLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME RIB-X PHARMACEUTICALS, INC. (US) 2008-11-27 — — WO disclosed
WO-2008106224-A1 MACROLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME RIB-X PHARMACEUTICALS, INC. (US) 2008-09-04 — — WO disclosed
WO-2008106204-A1 MACROLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME RIB-X-PHARMACEUTICALS, INC. (US) 2008-09-04 — — WO disclosed
WO-2008106226-A2 MACROLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME RIB-X PHARMACEUTICALS, INC. (US) 2008-09-04 — — WO disclosed
Send feedback